
|Articles|November 1, 2003
Iris reconstruction lens benefits aniridic patients
Indianapolis-The Model 311 Iris Reconstruction Lens (Ophtec) appears safe and has significant benefit for reducing visual disturbances in patients with partial or complete aniridia, according to the first reported results from the FDA phase I trial evaluating that implant.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Opuviz aflibercept biosimilar launches in Europe for retinal diseases
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















